CUSIP: 68236X118
What is CUSIP 68236X118?
CUSIP 68236X118 identifies TOIIW - Oncology Institute, Inc. - *W EXP 99/99/999 in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Open recent reporting periods for CUSIP 68236X118:
As of 31 Dec 2025, 11 institutional investors reported holding 3,894,708 shares of Oncology Institute, Inc. - *W EXP 99/99/999 (TOIIW).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 3,894,708 | $821,123 | -$11,170 | $0.12 | 11 |
| 2025 Q3 | 3,987,728 | $817,951 | +$358,706 | $0.12 | 12 |
| 2025 Q2 | 3,808,951 | $195,399 | +$15,251 | $0.05 | 11 |
| 2025 Q1 | 3,520,379 | $94,854 | -$299 | $0.03 | 11 |
| 2024 Q4 | 3,584,353 | $19,022 | +$3,389 | $0.01 | 14 |
| 2024 Q3 | 2,599,433 | $51,988 | -$42,814 | $0.02 | 15 |
| 2024 Q2 | 4,210,487 | $107,613 | +$2,833 | $0.03 | 15 |
| 2024 Q1 | 4,116,072 | $827,453 | -$74,159 | $0.20 | 15 |
| 2023 Q4 | 1,571,462 | $224,311 | +$5,741 | $0.13 | 11 |
| 2023 Q3 | 4,465,870 | $408,862 | -$12,496 | $0.09 | 16 |
| 2023 Q2 | 4,222,088 | $122,040 | -$3,646 | $0.03 | 11 |
| 2023 Q1 | 2,708,752 | $176,325 | -$3,033 | $0.07 | 11 |
| 2022 Q4 | 3,144,220 | $346,401 | -$65,186 | $0.11 | 13 |
| 2022 Q3 | 3,323,651 | $1,775,588 | +$47,864 | $0.55 | 13 |
| 2022 Q2 | 3,228,023 | $1,614,600 | -$140,933 | $0.50 | 12 |
| 2022 Q1 | 3,388,924 | $3,898,776 | -$265,424 | $1.15 | 13 |
| 2021 Q4 | 3,714,971 | $2,563,785 | +$2,477,785 | $0.69 | 21 |
| 2021 Q3 | $9.92 | 0 |